Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/791833/000114420407037827/v081672_ex99-1.htm
December 2008
November 2008
November 2008
June 2008
March 2008
December 2007
November 2007
August 2007
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/791833/000114420407037827/v081672_ex99-1.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Advanced Biotherapy Inc.
Advanced Biotherapy Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:
CIK: 791833Events:
Form Type: 8-K Corporate News
Accession Number: 0001144204-07-037827
Submitted to the SEC: Mon Jul 23 2007 4:46:27 PM EST
Accepted by the SEC: Mon Jul 23 2007
Period: Monday, July 23, 2007
Industry: Commercial Physical And Biological Research